Here, we determined whether the polymorphism of 6 SNPs within the RAD18 gene with MAF values of more than 5% was associated with the occurrence, progression, and prognostic risk of CIN III or CSCC. This evidence concerns the gene RAD18 and uterine cervix carcinoma in situ.